The Journal of Nutritional Biochemistry
Volume 21, Issue 8 , Pages 764-773 , August 2010

Conjugated nonadecadienoic acid is more potent than conjugated linoleic acid on body fat reduction

Received 18 February 2009 ,Revised 1 May 2009 ,Accepted 8 May 2009.

References 

  1. Park Y, Pariza MW. Mechanisms of body fat modulation by conjugated linoleic acid (CLA). Food Res Int. 2007;40:311–323
  2. Pariza MW. Perspective on the safety and effectiveness of conjugated linoleic acid. Am J Clin Nutr. 2004;79:1132S–1136S
  3. Storkson JM, Park Y, Cook ME, Pariza MW. Effects of trans-10,cis-12 conjugated linoleic acid (CLA) and cognates on apolipoprotein B secretion in HepG2 cells. Nutr Res. 2005;25:387–399
  4. Park Y, Storkson JM, Liu W, Albright KJ, Cook ME, Pariza MW. Structure–activity relationship of conjugated linoleic acid and its cognates in inhibiting heparin-releasable lipoprotein lipase and glycerol release from fully differentiated 3T3-L1 adipocytes. J Nutr Biochem. 2004;15:561–568
  5. Park Y, Storkson JM, Ntambi JM, Cook ME, Sih CJ, Pariza MW. Inhibition of hepatic stearoyl-CoA desaturase activity by trans-10, cis-12 conjugated linoleic acid and its derivatives. Biochim Biophys Acta. 2000;1486:285–292
  6. Park YPariza MW. The effects of dietary conjugated nonadecadienoic acid on body composition in mice. Biochim Biophys Acta. 2001;1533:171–174
  7. Park Y, Storkson JM, Albright KJ, Liu W, Pariza MW. Biological activities of conjugated fatty acids: conjugated eicosadienoic (conj. 20:2delta(c11,t13/t12,c14)), eicosatrienoic (conj. 20:3delta(c8,t12,c14)), and heneicosadienoic (conj. 21:2delta(c12,t14/c13,t15)) acids and other metabolites of conjugated linoleic acid. Biochim Biophys Acta. 2005;1687:120–129
  8. Wahle KW, Heys SD, Rotondo D. Conjugated linoleic acids: are they beneficial or detrimental to health?. Prog Lipid Res. 2004;43:553–587
  9. Pariza MW, Park Y, Cook ME. The biologically active isomers of conjugated linoleic acid. Prog Lipid Res. 2001;40:283–298
  10. Park Y, Storkson JM, Albright KJ, Liu W, Pariza MW. Evidence that the trans-10,cis-12 isomer of conjugated linoleic acid induces body composition changes in mice. Lipids. 1999;34:235–241
  11. Choi CS, Savage DB, Abu-Elheiga L, Liu ZX, Kim S, Kulkarni A, et al. Continuous fat oxidation in acetyl-CoA carboxylase 2 knockout mice increases total energy expenditure, reduces fat mass, and improves insulin sensitivity. Proc Natl Acad Sci U S A. 2007;104:16480–16485
  12. Wargent E, Sennitt MV, Stocker C, Mayes AE, Brown L, O'dowd J, et al. Prolonged treatment of genetically obese mice with conjugated linoleic acid improves glucose tolerance and lowers plasma insulin concentration: possible involvement of PPAR activation. Lipids Health Dis. 2005;4:3
  13. Helrich K. Official methods of analysis. 1990;935-937.
  14. West DB, Blohm FY, Truett AA, DeLany JP. Conjugated linoleic acid persistently increases total energy expenditure in AKR/J mice without increasing uncoupling protein gene expression. J Nutr. 2000;130:2471–2477
  15. Terpstra AH, Beynen AC, Everts H, Kocsis S, Katan MB, Zock PL. The decrease in body fat in mice fed conjugated linoleic acid is due to increases in energy expenditure and energy loss in the excreta. J Nutr. 2002;132:940–945
  16. Wang Y, Jones PJ. Dietary conjugated linoleic acid and body composition. Am J Clin Nutr. 2004;79:1153S–1158S
  17. Tsuboyama-Kasaoka N, Miyazaki H, Kasaoka S, Ezaki O. Increasing the amount of fat in a conjugated linoleic acid–supplemented diet reduces lipodystrophy in mice. J Nutr. 2003;133:1793–1799
  18. Ryder JW, Portocarrero CP, Song XM, Cui L, Yu M, Combatsiaris T, et al. Isomer-specific antidiabetic properties of conjugated linoleic acid. improved glucose tolerance, skeletal muscle insulin action, and UCP-2 gene expression. Diabetes. 2001;50:1149–1157
  19. Park Y, Albright KJ, Liu W, Storkson JM, Cook ME, Pariza MW. Effect of conjugated linoleic acid on body composition in mice. Lipids. 1997;32:853–858
  20. Bouthegourd JC, Even PC, Gripois D, Tiffon B, Blouquit MF, Roseau S, et al. A CLA mixture prevents body triglyceride accumulation without affecting energy expenditure in Syrian hamsters. J Nutr. 2002;132:2682–2689
  21. West DB, Delany JP, Camet PM, Blohm F, Truett AA, Scimeca J. Effects of conjugated linoleic acid on body fat and energy metabolism in the mouse. Am J Physiol. 1998;275:R667–R672
  22. Nazare JA, de la Perriere AB, Bonnet F, Desage M, Peyrat J, Maitrepierre C, et al. Daily intake of conjugated linoleic acid-enriched yoghurts: effects on energy metabolism and adipose tissue gene expression in healthy subjects. Br J Nutr. 2007;97:273–280
  23. Lasa A, Simon E, Churruca I, Fernandez-Quintela A, Rodriguez VM, Portillo MP. Adiposity and serum parameters in hamsters fed energy restricted diets supplemented or not with trans-10,cis-12 conjugated linoleic acid. J Physiol Biochem. 2007;63:297–304
  24. Moon HS, Lee HG, Seo JH, Chung CS, Kim TG, Kim IY, et al. Down-regulation of PPARgamma2-induced adipogenesis by PEGylated conjugated linoleic acid as the pro-drug: attenuation of lipid accumulation and reduction of apoptosis. Arch Biochem Biophys. 2006;456:19–29
  25. Chung S, Brown JM, Provo JN, Hopkins R, McIntosh MK. Conjugated linoleic acid promotes human adipocyte insulin resistance through NFkappaB-dependent cytokine production. J Biol Chem. 2005;280:38445–38456
  26. Evans M, Park Y, Pariza M, Curtis L, Kuebler B, McIntosh M. Trans-10,cis-12 conjugated linoleic acid reduces triglyceride content while differentially affecting peroxisome proliferator activated receptor gamma2 and aP2 expression in 3T3-L1 preadipocytes. Lipids. 2001;36:1223–1232
  27. Granlund L, Juvet LK, Pedersen JI, Nebb HI. Trans10, cis12-conjugated linoleic acid prevents triacylglycerol accumulation in adipocytes by acting as a PPARgamma modulator. J Lipid Res. 2003;44:1441–1452
  28. Miner JL, Cederberg CA, Nielsen MK, Chen X, Baile CA. Conjugated linoleic acid (CLA), body fat, and apoptosis. Obes Res. 2001;9:129–134
  29. Hargrave KM, Li C, Meyer BJ, Kachman SD, Hartzell DL, Della-Fera MA, et al. Adipose depletion and apoptosis induced by trans-10, cis-12 conjugated linoleic acid in mice. Obes Res. 2002;10:1284–1290
  30. Tsuboyama-Kasaoka N, Takahashi M, Tanemura K, Kim HJ, Tange T, Okuyama H, et al. Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice. Diabetes. 2000;49:1534–1542
  31. Hotamisligil GS, Spiegelman BM. Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes. 1994;43:1271–1278
  32. Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature. 2006;444:875–880
  33. Nagao K, Inoue N, Wang YM, Shirouchi B, Yanagita T. Dietary conjugated linoleic acid alleviates nonalcoholic fatty liver disease in Zucker (fa/fa) rats. J Nutr. 2005;135:9–13
  34. Yang M, Cook ME. Dietary conjugated linoleic acid decreased cachexia, macrophage tumor necrosis factor-alpha production, and modifies splenocyte cytokines production. Exp Biol Med (Maywood). 2003;228:51–58
  35. Wendel AA, Purushotham A, Liu LF, Belury MA. Conjugated linoleic acid fails to worsen insulin resistance but induces hepatic steatosis in the presence of leptin in ob/ob mice. J Lipid Res. 2008;49:98–106
  36. Purushotham A, Wendel AA, Liu LF, Belury MA. Maintenance of adiponectin attenuates insulin resistance induced by dietary conjugated linoleic acid in mice. J Lipid Res. 2007;48:444–452
  37. Perez-Matute P, Marti A, Martinez JA, Fernandez-Otero MP, Stanhope KL, Havel PJ, et al. Conjugated linoleic acid inhibits glucose metabolism, leptin and adiponectin secretion in primary cultured rat adipocytes. Mol Cell Endocrinol. 2007;268:50–58
  38. Malpuech-Brugere C, Verboeket-van de Venne WP, Mensink RP, Arnal MA, Morio B, Brandolini M, et al. Effects of two conjugated linoleic acid isomers on body fat mass in overweight humans. Obes Res. 2004;12:591–598
  39. Whigham LD, Watras AC, Schoeller DA. Efficacy of conjugated linoleic acid for reducing fat mass: a meta-analysis in humans. Am J Clin Nutr. 2007;85:1203–1211
  40. Park Y, Albright KJ, Storkson JM, Liu W, Pariza MW. Conjugated linoleic acid (CLA) prevents body fat accumulation and weight gain in an animal model. J Food Sci. 2007;72:S612–S617
  41. Terpstra AH. Differences between humans and mice in efficacy of the body fat lowering effect of conjugated linoleic acid: role of metabolic rate. J Nutr. 2001;131:2067–2068
  42. Kamphuis MM, Lejeune MP, Saris WH, Westerterp-Plantenga MS. The effect of conjugated linoleic acid supplementation after weight loss on body weight regain, body composition, and resting metabolic rate in overweight subjects. Int J Obes Relat Metab Disord. 2003;27:840–847
  43. Larsen TM, Toubro S, Gudmundsen O, Astrup A. Conjugated linoleic acid supplementation for 1 y does not prevent weight or body fat regain. Am J Clin Nutr. 2006;83:606–612
  44. Park Y, Pariza MW, Park Y. Co-supplementation of dietary calcium and conjugated linoleic acid (CLA) improves bone mass in mice. J Food Sci. 2008;73:C556–C560
  45. Kritchevsky D, Tepper SA, Wright S, Tso P, Czarnecki SK. Influence of conjugated linoleic acid (CLA) on establishment and progression of atherosclerosis in rabbits. J Am Coll Nutr. 2000;19:472S–477S
  46. Navarro V, Miranda J, Churruca I, Fernandez-Quintela A, Rodriguez VM, Portillo MP. Effects of trans-10,cis-12 conjugated linoleic acid on body fat and serum lipids in young and adult hamsters. J Physiol Biochem. 2006;62:81–87
  47. Wilson TA, Nicolosi RJ, Saati A, Kotyla T, Kritchevsky D. Conjugated linoleic acid isomers reduce blood cholesterol levels but not aortic cholesterol accumulation in hypercholesterolemic hamsters. Lipids. 2006;41:41–48
  48. Clement L, Poirier H, Niot I, Bocher V, Guerre-Millo M, Krief S, et al. Dietary trans-10,cis-12 conjugated linoleic acid induces hyperinsulinemia and fatty liver in the mouse. J Lipid Res. 2002;43:1400–1409
  49. Poirier H, Niot I, Clement L, Guerre-Millo M, Besnard P. Development of conjugated linoleic acid (CLA)-mediated lipoatrophic syndrome in the mouse. Biochimie. 2005;87:73–79
  50. Yanagita T, Wang YM, Nagao K, Ujino Y, Inoue N. Conjugated linoleic acid-induced fatty liver can be attenuated by combination with docosahexaenoic acid in C57BL/6N mice. J Agric Food Chem. 2005;53:9629–9633
  51. Moya-Camarena SY, Vanden Heuvel JP, Blanchard SG, Leesnitzer LA, Belury MA. Conjugated linoleic acid is a potent naturally occurring ligand and activator of PPARalpha. J Lipid Res. 1999;40:1426–1433
  52. Purushotham A, Shrode GE, Wendel AA, Liu LF, Belury MA. Conjugated linoleic acid does not reduce body fat but decreases hepatic steatosis in adult Wistar rats. J Nutr Biochem. 2007;18:676–684
  53. Park Y, Albright KJ, Pariza MW. Effects of conjugated linoleic acid on long term feeding in Fischer 344 rats. Food Chem Toxicol. 2005;43:1273–1279
  54. O'Hagan S, Menzel A. A subchronic 90-day oral rat toxicity study and in vitro genotoxicity studies with a conjugated linoleic acid product. Food Chem Toxicol. 2003;41:1749–1760
  55. Whigham LD, O'Shea M, Mohede IC, Walaski HP, Atkinson RL. Safety profile of conjugated linoleic acid in a 12-month trial in obese humans. Food Chem Toxicol. 2004;42:1701–1709
  56. Houseknecht KL, Vanden Heuvel JP, Moya-Camarena SY, Portocarrero CP, Peck LW, Nickel KP, et al. Dietary conjugated linoleic acid normalizes impaired glucose tolerance in the Zucker diabetic fatty fa/fa rat. Biochem Biophys Res Commun. 1998;244:678–682
  57. Eyjolfson V, Spriet LL, Dyck DJ. Conjugated linoleic acid improves insulin sensitivity in young, sedentary humans. Med Sci Sports Exerc. 2004;36:814–820
  58. Riserus U, Vessby B, Arner P, Zethelius B. Supplementation with trans10cis12-conjugated linoleic acid induces hyperproinsulinaemia in obese men: close association with impaired insulin sensitivity. Diabetologia. 2004;47:1016–1019
  59. Dumke CL, Gazdag AC, Fechner K, Park Y, Pariza MW, Cartee GD. Skeletal muscle glucose transport in conjugated linoleic acid (CLA) fed mice. Med Sci Sports Exercise. 2000;32:S226
  60. Everett-Grueter C, Edgerton DS, Donahue EP, Vaughan S, Chu CA, Sindelar DK, et al. The effect of an acute elevation of NEFA concentrations on glucagon-stimulated hepatic glucose output. Am J Physiol Endocrinol Metab. 2006;291:E449–E459

PII: S0955-2863(09)00105-3

doi: 10.1016/j.jnutbio.2009.05.003

The Journal of Nutritional Biochemistry
Volume 21, Issue 8 , Pages 764-773 , August 2010

Article Tools

* Image Usage & Resolution